Alliancebernstein L.P. Oyster Point Pharma, Inc. Transaction History

Alliancebernstein L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.6 - $11.2 $53,640 - $166,880	-14,900 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$16.25 - $21.51 $19,500 - $25,812	1,200 Added 8.76%	14,900 $256,000
Q1 2021 May 06, 2021	SELL	$17.92 - $25.86 $17,920 - $25,860	-1,000 Reduced 6.8%	13,700 $250,000
Q4 2020 Feb 08, 2021	BUY	$18.13 - $25.18 $25,382 - $35,252	1,400 Added 10.53%	14,700 $277,000
Q3 2020 Nov 12, 2020	SELL	$17.83 - $29.12 $14,263 - $23,296	-800 Reduced 5.67%	13,300 $281,000
Q2 2020 Aug 13, 2020	BUY	$27.86 - $35.93 $392,826 - $506,613	14,100 New	14,100 $407,000

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.